Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: J Urol. 2011 Jun 15;186(2):482–486. doi: 10.1016/j.juro.2011.03.111

TABLE 2.

Baseline Subject Characteristics by Prevalent Fracture, age > 70

No Prevalent Fractures Prevalent Fractures
N (%)Mean ± SD N (%)Mean ± SD p-value
Overall cohort 871 (100%) 131 (100%) .
Age 78.6 ± 0.17 78.72 ± 0.43 0.853
Residence 0.171
 Mexico 125 (14.35) 13 (9.92) .
 USA 746 (85.65) 118 (90.08) .
Race 0.035
 White 635 (72.90) 109 (83.21) .
 Other 236 (27.10) 22 (16.79) .
BMI 28.15 ± 0.14 28.09 ± 0.40 0.732
ADT duration 0.647
 <= 1 year 136 (16.23) 18 (14.40) .
 > 1 year 702 (83.77) 107 (85.60) .
ADT 0.412
 GnRH agonist 801 (91.96) 120 (91.60) .
 bilateral orchiectomies 70 (8.04) 11 (8.40) .
Testosterone 31.61 ± 2.44 23.47 ± 0.76 0.274
Estradiol 12.17 ± 0.28 11.25 ± 0.65 0.185
Estradiol 0.096
 <= median 430 (51.37) 76 (58.46) .
 > median 407 (48.63) 54 (41.54) .
CTX 0.59 ± 0.01 0.59 ± 0.02 0.997
BSAP 28.93 ± 0.45 29.43 ± 0.82 0.537
Osteocalcin 11.47 ± 0.20 11.77 ± 0.43 0.640